期刊文献+

血清脂联素与胱抑素C检测在糖尿病肾病早期诊断中的价值 被引量:6

EARLY DIAGNOSTIC VALUE OF SERUM ADIPONECTIN AND CYSTATIN C FOR DIABETIC NEPHROPATHY
原文传递
导出
摘要 目的分析血清脂联素及胱抑素C在糖尿病肾病早期诊断中的价值。方法选取糖尿病患者组85例作为观察对象,并根据尿蛋白排泄率分为三组:正常蛋白尿组,微量蛋白尿组及临床蛋白尿组,同时选择健康体检者30例作为正常对照组。采用酶联免疫吸附试验(ELISA)检测血清脂联素水平,免疫比浊法检测血清胱抑素。结果糖尿病组血清脂联素及胱抑素水平明显低于正常对照组(P<0.05),而随尿蛋白排泄率的增加,血清脂联素及胱抑素水平逐渐增高(P<0.05),且血清脂联素与胱抑素呈正相关关系(r=0.652,P<0.05)。结论糖尿病患者血清APN水平的升高预示肾功能的减退,可用于糖尿病肾病的早期诊断。 Objective To evaluate the value of adiponectin and cystatin C on early diagnosis for renal impairment in diabetes. Methods A total of 85 diabetic patients were divided into normal albuminuria group, micro- albuminuria group and macro- albuminuria group according to urine albumin excretion rate in 24 hours. 30 health subjects were enrolled as controls. The serum levels of adiponectin and cys- tatin C were detected by ELISA kit. Results The serum levels of adiponectin and cystatin C in diabetic patients were obviously lower than that in the controls(P〈0.05). For diabetic patients, the serum levels of adiponectin and cystatin C in macro- albuminuria group were significantly higher than in mi- cro- albuminuria group (P 〈 0. 05). and they were also significantly higher in micro- albuminura group then that in normal albuminura group(P〈0.05). The serum level of adiponectin in diabetic pa- tients was positively correlated with the serum levels of cystatin C(r = 0. 652,P〈0.05). Conclusion In diabetic patients, the elevated serum levels of adiponectin indicates the decline of renal function. It can be used for the early diagnosis and estimation of diabetic nephropathy.
出处 《中国煤炭工业医学杂志》 2014年第2期248-250,共3页 Chinese Journal of Coal Industry Medicine
关键词 血清脂联素 血清胱抑素 糖尿病 糖尿病肾病 Serum adiponectin Serum cystatin Diabtes~ Diabetic nephropathy
  • 相关文献

参考文献11

  • 1林忆阳.血清脂联素水平与2型糖尿病肾病的相关性研究[J].实用预防医学,2010,17(10):2098-2100. 被引量:4
  • 2Lesley Coresh,Christopher. Estimating GFR using Serum Cystatin C Alone and in Combination with- Serum Creatinine. A Pooled Analysis of 341 8 Indi- vidualswith CKD[J]. Am J Kidney Dis, 2008,51 (3) 1395 - 406.
  • 3傅祖植 叶任高 陆再英 主编.糖尿病[A].叶任高,陆再英,主编.内科学.第6版[C].北京:人民卫生出版社,2004.787-814.
  • 4Hadjadj S,Aubert R, Fumeron F, et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects [J]. Diabetologia,2005,48(6) . 1088- 1092.
  • 5Sarahemo M, Forsblom C, Thorn L, et al. Serum adiponecin and progression of diabetic nephropa- thy in patients with type 1 diabetes[J]. Diabetes Care,2008,31(6) . 1165 - 1169.
  • 6Schalkw G,Chaturvedi N,Schram MT,et al. Adi- ponectin is inversely associated with renal function in type 1 diabetic patients [J]. J Clin Endocrino Metab,2006,91(1) .- 129 - 135.
  • 7洪洁,顾卫琼,张翼飞,唐金凤,杨颖,陈宇红,孙首悦,赵咏桔,宁光.胰岛素抵抗综合征患者血清脂联素和胰岛素敏感性的相关性研究[J].中华内分泌代谢杂志,2003,19(3):173-176. 被引量:93
  • 8Hoffstedt J, Arvidson E, Sjolin E, et al. Adipose tissue adiponeetin production and adiponectin ser- um concentration in human obesity and insulin re- sistance[-J']. J Clin Endocrino Metab,2004,89(3) ; 1391.
  • 9杭永伦,温先勇,徐勇.血胱蛋白酶抑制剂C对糖尿病早期肾脏损害的诊断价值[J].医学理论与实践,2006,19(1):15-17. 被引量:9
  • 10Conti M, Moutereau S, Zater M, et al. Urinarycys- tatinCasaspecif - icmarkeroftubulardysfunction [J]. Clin Chem Lab Med,2006,44(3) : 288 - 291.

二级参考文献31

  • 1肖正大,韩改玲,李静,张荣花.2型糖尿病肾病患者血清脂联素水平分析[J].山东大学学报(医学版),2006,44(1):69-72. 被引量:14
  • 2Kopp HP, Krzyzanowska K, Mohlig M, et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women[J]. Int J Obes( Lond), 2005,29 (7) : 766 - 771.
  • 3Fu Y, Luo N, Klein RL, et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation [J]. J Lipid Res, 2005,46(7):1369 -1379.
  • 4Lihn AS, Ostergard T, Nyholm B, et al. Adiponectin expression in adipose tissue is reduced in first - degree relatives of type 2 diabetic patients [J]. Am J Physiol Endocrinol Metab,2003,284(2) :443 - 448.
  • 5Yamauchi T, Kamon J, Waki H, et al. Globular adiponeetin protected ob/ob mice from diabetes and ApoE - deficient mice from atheroselerosis [ J ]. J Biol Chem, 2003,78 (4) : 2461 - 2468.
  • 6Hotta K, Funahashi T, Arita Y, et al. Plasma concentration of a novel,adipose-specific protein, adiponectin, in type 2 diabetic patients.Arterioscler Thromb Vasc Biol, 2000,20 : 1595-1599.
  • 7Bergman RN. Toward physiological understanling of glucose tolerance.Minimal-model approach. Diabetes, 1989,38 : 1512-1527.
  • 8Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome. Diabetes, 2002,51:2325-2328.
  • 9Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999,257:79-83.
  • 10Hotta K, Funahashi T, Bodkin N, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in Rhesus monkeys. Diabetes, 2001,1126-1133.

共引文献139

同被引文献66

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部